
Interesting piece on @PainChek ($PCK) and its push into the US market.
The appointment of @4DMedicalXV Chair Lil Bianchi looks significant given the similarities between the two SaaS healthcare expansion stories.
Key points:
- FDA De Novo clearance secured
- @PointClickCare integration across ~1.5m US aged care beds
- Sabra agreement creating a potential 20,000+ bed rollout pathway
- UK business now >10% market penetration
- Australia already operationally break-even
Feels like the market is starting to look at PCK through a very different lens.
Read via @techinvestmag 👇
techinvest.online/news/painchek-…

English
















